Last reviewed · How we verify

Human Plasma

Ottawa Hospital Research Institute · FDA-approved active Small molecule Quality 5/100

Human Plasma is a Small molecule drug developed by Ottawa Hospital Research Institute. It is currently FDA-approved. Also known as: non applicable.

At a glance

Generic nameHuman Plasma
Also known asnon applicable
SponsorOttawa Hospital Research Institute
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Human Plasma

What is Human Plasma?

Human Plasma is a Small molecule drug developed by Ottawa Hospital Research Institute.

Who makes Human Plasma?

Human Plasma is developed and marketed by Ottawa Hospital Research Institute (see full Ottawa Hospital Research Institute pipeline at /company/ottawa-hospital-research-institute).

Is Human Plasma also known as anything else?

Human Plasma is also known as non applicable.

What development phase is Human Plasma in?

Human Plasma is FDA-approved (marketed).

Related

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing